The Bronx, NYNCT06892678Now EnrollingIRB Ready

Osteosarcoma Recurrent Clinical Trial in The Bronx, NY

Access cutting-edge osteosarcoma recurrent treatment through this phase 1/2 clinical trial at a research site in The Bronx. Study-provided care at no cost to qualified participants.

Sponsored by Montefiore Medical Center

Quick Self-Assessment

See if you qualify for this The Bronx location

Preparing your pre-screening questions…

Expert Care in The Bronx

Access osteosarcoma recurrent specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteosarcoma recurrent treatment provided free

Apply for This The Bronx Location

Check if you qualify for this osteosarcoma recurrent clinical trial in The Bronx, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to The Bronx

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit The Bronx site if eligible
  4. 4Begin participation

About This Osteosarcoma Recurrent Study in The Bronx

The purpose of this study is to determine the feasibility of administering DL-alpha-difluoromethylornithine (DFMO) to patients with relapsed Ewing sarcoma and osteosarcoma who have completed all planned therapy and have no evidence of disease.

Sponsor: Montefiore Medical Center

Who Can Participate

Inclusion Criteria

Patients \< 40 years of age at the time of enrollment
Diagnosis of relapsed osteosarcoma or relapsed Ewing sarcoma who have completed all planned therapy for their relapse, as described in the protocol, and have no evidence of disease
Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2
Myelosuppressive chemotherapy: At least 14 days must have elapsed since completion of myelosuppressive therapy
Monoclonal antibodies: At least 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to Grade \< 2
Biologic therapy (defined as anti-cancer agents not known to be myelosuppressive): At least 7 days after the last dose of agent
Radiation therapy: At least 14 days must have elapsed after local External Beam Radiation Therapy (XRT), at least 90 days after Total Body Irradiation (TBI), craniospinal XRT or if radiation to greater than 50% of the pelvis, and at least 42 days if other substantial bone marrow radiation
Adequate bone marrow function defined as:
Peripheral absolute neutrophil count (ANC) greater or equal to 750/microliter
Platelet count greater or equal to 75,000/microliter (transfusion independent)
Adequate renal function defined by serum creatinine based on age and gender (see protocol)
Adequate liver function defined as:
Total bilirubin ≤ 1.5 x the upper limit of normal (ULN) for age AND
SGPT (ALT) ≤ 5.0 x ULN for age. For this study the ULN is 45 U/L

Exclusion Criteria

Pregnant or breastfeeding females. Men and women of childbearing potential and their partners must agree to use adequate contraception while enrolled on this study. Based on the teratogenic potential of the agent, pregnant women will be excluded from this study. Because of potential risks to breastfed infants due to drug metabolites that could be excreted in breast milk, female patients who are lactating must agree to stop breastfeeding or will otherwise be excluded from this study. Females of childbearing potential must have a negative pregnancy test to be eligible for this study
Patients must not have an uncontrolled infection
Patients with a significant intercurrent illness (any ongoing serious medical problem unrelated to cancer or its treatment) that is not covered by the detailed exclusion criteria and that is expected to interfere with the action of study agents or to significantly increase the severity of the toxicities experienced from study treatment are not eligible

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in The Bronx?

Yes, this clinical trial (NCT06892678) has an active research site in The Bronx, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteosarcoma Recurrent Treatment Options in The Bronx, NY

If you're searching for osteosarcoma recurrent treatment options in The Bronx, NY, this clinical trial (NCT06892678) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our The Bronx research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced osteosarcoma recurrent specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteosarcoma recurrent clinical trials near you to find additional studies recruiting in your area.

More Sarcoma Trials in The Bronx, NY

See all sarcoma clinical trials recruiting in The Bronx — not just this study.

Browse Sarcoma Trials in The Bronx →

Browse More Trials by Condition

Sarcoma TrialsSleep Apnea TrialsAll Conditions →

Ready to Join in The Bronx?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · The Bronx, NY